Second, epigenetic modifications can affect gene expression related to metabolic pathways (e.g., insulin signaling, adipogenesis, and lipid metabolism), increasing susceptibility to obesity and diabetes later in life [36–38]. This evidence concerns the gene INS and diabetes mellitus.